Skip to main content
SpringerLink
Log in

Early Markers in Parkinson’s and Alzheimer’s Diseases

  • Book
  • © 1990

Overview

Editors:
  1. Philippe Dostert

    1. Farmitalia Carlo Erba, R & D, Milan, Italy

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Peter Riederer

    1. Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Würzburg, Federal Republic of Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. Margherita Strolin Benedetti

    1. Farmitalia Carlo Erba, R & D, Milan, Italy

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  4. Romeo Roncucci

    1. Farmitalia Carlo Erba, R & D, Milan, Italy

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: New Vistas in Drug Research (DRUG RESEARCH, volume 1)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (26 chapters)

  1. Front Matter

    Pages I-XX
    Download chapter PDF

  2. Introduction

    1. Introduction

      • R. Levi Montalcini
      Pages 1-1

  3. Early markers in Parkinson’s disease

    1. Front Matter

      Pages 3-3
      Download chapter PDF

    2. Early markers in Parkinson’s disease

      • H. Przuntek
      Pages 5-11

    3. Differential diagnosis of Parkinson’s disease

      • A. Agnoli, F. Stocchi, A. Carta
      Pages 13-21

    4. The premorbid personality of patients with Parkinson’s disease

      • W. Poewe
      Pages 23-30

    5. An antibody in the CSF of Parkinson’s disease patients: summary of data and potential role as a diagnostic marker

      • P. M. Carvey, H. L. Klawans, L. C. Kao, A. Dahlström, A. McRae
      Pages 31-40

    6. Contribution of motor performance tests to the early diagnosis of Parkinson’s disease

      • P. H. Kraus, P. Klotz, R. Steinberg, H. Przuntek
      Pages 41-48

    7. Electrophysiological methods in the early diagnosis of Parkinson’s disease

      • C. H. Lücking, A. Hufschmidt, G. Deuschl
      Pages 49-57

    8. Characterisation of Parkinson’s disease using positron emission tomography

      • K. L. Leenders
      Pages 59-69

    9. Dopamine beta-hydroxylase and beta 2-microglobulin in cerebrospinal fluid: early markers in Parkinson’s disease?

      • T. Nagastu, M. Mogi, M. Harada, K. Kojima
      Pages 71-78

    10. Urinary dopamine sulfate conjugates in Parkinson’s disease

      • E. Kienzl, K. Eichinger, K. Jellinger, W. Kuhn, G. Fuchs, W. Danielczyk et al.
      Pages 79-92

    11. Salsolinol and the early detection of Parkinson’s disease

      • P. Dostert, M. Strolin Benedetti, G. Dordain
      Pages 93-97

    12. MR imaging of putamenal iron predicts response to dopaminergic therapy in parkinsonian patients

      • C. W. Olanow, M. Alberts, W. Djang, J. Stajich
      Pages 99-109

    13. The neurotoxic component in Parkinson’s disease may involve iron-melanin interaction and lipid peroxidation in the substantia nigra

      • M. B. H. Youdim, D. Ben-Shachar
      Pages 111-122

  4. Early markers in Alzheimer’s disease

    1. Front Matter

      Pages 135-135
      Download chapter PDF

    2. The need for early markers in Alzheimer’s disease

      • D. L. Murphy, T. Sunderland
      Pages 137-146

    3. Descriptive and analytic epidemiology of Alzheimer’s disease

      • L. Amaducci, A. Lippi
      Pages 147-154

    4. Differential diagnosis of early Alzheimer’s disease

      • C. G. Gottfries
      Pages 155-163

    5. Down syndrome: a model for the study of Alzheimer’s disease and aging

      • J. M. Delabar, J. L. Blouin, Z. Rahmani, N. Créau-Goldberg, Z. Chettouh, A. Nicole et al.
      Pages 165-179
Back to top

Keywords

About this book

The aim of Early Markers in Parkinson's and Alzheimer's Diseases is to provide the reader with updated data on various approaches whose investigation and development could contribute to the discovery of early diag- nostic markers of these two degenerative diseases. Concerning Parkinson's disease, some of the topics dealt with in the book will help update the information previously reported in Early Diagnosis and Preventive Therapy in Parkinson's Disease. Concerning Alzheimer's disease, the scope and limitations of electrophysiological and brain imaging techniques with regards to early detection of the disease are documented. Various biochemical parameters, such as brain energy metabolism, levels of choline, and platelet monoamine oxidase activity are envisaged as some of the starting points for the discovery of early diagnostic markers of Alzheimer's disease.

Editors and Affiliations

  • Farmitalia Carlo Erba, R & D, Milan, Italy

    Philippe Dostert, Margherita Strolin Benedetti, Romeo Roncucci

  • Clinical Neurochemistry, Department of Psychiatry, University of Würzburg, Würzburg, Federal Republic of Germany

    Peter Riederer

Bibliographic Information

  • Book Title: Early Markers in Parkinson’s and Alzheimer’s Diseases

  • Editors: Philippe Dostert, Peter Riederer, Margherita Strolin Benedetti, Romeo Roncucci

  • Series Title: New Vistas in Drug Research

  • DOI: https://doi.org/10.1007/978-3-7091-9098-2

  • Publisher: Springer Vienna

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag/Wien 1990

  • Softcover ISBN: 978-3-7091-9100-2Published: 09 January 2012

  • eBook ISBN: 978-3-7091-9098-2Published: 06 December 2012

  • Series ISSN: 0938-9245

  • Edition Number: 1

  • Number of Pages: XX, 310

  • Topics: Neurology, Neurosciences

Publish with us

Policies and ethics

Back to top

Search

Navigation